A pickup in the pace of innovation—potentially from recent advances in robotics and generative AI—remains the catalyst most likely to reverse long-run stagnation in manufacturing productivity.
Roche's $50 billion investment in US manufacturing aims to create over 12,000 jobs and counter potential tariffs, marking a significant commitment to innovation and growth.